LUCD — Lucid Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $201.11m
- $244.68m
- $4.71m
Annual cashflow statement for Lucid Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.1 | -56.2 | -52.7 | -45.5 | -58 |
| Depreciation | |||||
| Non-Cash Items | 9.6 | 15.6 | 11.7 | 4.65 | 13.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.807 | 8.91 | 5.67 | -4.43 | -2.81 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -17.7 | -29.7 | -32.8 | -44.1 | -46.5 |
| Capital Expenditures | -0.862 | -0.908 | -0.221 | -0.646 | -0.197 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -3.2 | 0 | — | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | -0.862 | -4.11 | -0.221 | -0.646 | -0.197 |
| Financing Cash Flow Items | 2.08 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 72.1 | 2.61 | 29.5 | 48.2 | 59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 53.5 | -31.2 | -3.58 | 3.46 | 12.3 |